Skip to content

Axogen AXGN EV / sales

EV / sales at other companies

Baxter International logo
Baxter InternationalBAX
0.6×-0.8×
Stryker logo
StrykerSYK
5.4×-1.3×
IAR
Integra LifeSciencesIART
1.5×-0.6×
LeMaitre Vascular logo
LeMaitre VascularLMAT
9.7×+1.3×
Medtronic logo
MedtronicMDT
3.6×-0.4×

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.26B+110%

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Calculated from Axogen’s reported figures.

Based on the most recent quarter.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's EV / sales?
Axogen (AXGN) reported EV / sales of 7× in Q1 2026.
How has Axogen's EV / sales changed year-over-year?
Axogen's EV / sales increased by 56.4% year-over-year, from 4.4× to 7×.
What is the long-term trend for Axogen's EV / sales?
Over 5 years (2020 to 2025), Axogen's EV / sales has grown at a 1.1% compound annual growth rate (CAGR), from 6.5× to 6.8×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.